alpha-Neup5Ac-(2->8)-alpha-Neup5Ac

Term ID

CHEBI:62097

Synonyms

(6R)-5-(acetylamino)-6-[(1S,2R)-2-({(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}oxy)-1,3-dihydroxypropyl]-3,5-dideoxy-beta-L-threo-hex-2-ulopyranosonic acid
(6R)-5-acetamido-6-[(1S,2R)-2-({(6R)-5-acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-alpha-L-threo-hex-2-ulopyranonosyl}oxy)-1,3-dihydroxypropyl]-3,5-dideoxy-alpha-L-threo-hex-2-ulopyranosonic acid
(6R)-5-acetamido-6-[(1S,2R)-2-({(6R)-5-acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}oxy)-1,3-dihydroxypropyl]-3,5-dideoxy-beta-L-threo-hex-2-ulopyranosonic acid
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
alpha-Neu5Ac-(2->8)-alpha-Neu5Ac
alpha-NeuAc-(2->8)-alpha-NeuAc
alpha-NeupNAc-(2->8)-alpha-NeupNAc
DS
Neu5Acalpha2-8Neu5Acalpha
NeuAc(alpha2-8)NeuAc
NeuAc(alpha2-8)NeuAcbeta
NeuAc(alpha2->8)NeuAc
NeuAc(alpha2->8)NeuAcalpha
WURCS=2.0/1,2,1/[Aad21122h-2a_2-6_5*NCC/3=O]/1-1/a8-b2

(all 14)

Definition

alpha-Neu5Ac-(2->8)-Neu5Ac in which the configuration at the anomeric carbon atom of the residue at the reducing end is alpha

References

(all 6)

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-Neu5Ac-(2->8)-Neu5Ac

alpha-Neu5Ac-(2->8)-Neu5Ac Show first 5 Terms
has_role: epitope

epitope Show first 5 Terms
inverse is_substituent_group_from: alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl group

alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl group Show first 5 Terms

Phenotype

Phenotype resulting from alpha-Neup5Ac-(2->8)-alpha-Neup5Ac

Phenotype where environments contain alpha-Neup5Ac-(2->8)-alpha-Neup5Ac

Phenotype modified by environments containing alpha-Neup5Ac-(2->8)-alpha-Neup5Ac

Phenotype affecting alpha-Neup5Ac-(2->8)-alpha-Neup5Ac

Human Disease Model